The North America Microcarriers Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).
Production of vaccines is by far the most common use of microcarrier-based culture in bioreactors. This involves creating modified viruses used as vaccines using a cell line used for "packing." Vero cells and, to a lesser extent, MRC-5 cells, which have essentially been replaced, are the cell types that are employed the most frequently.
It is also possible to produce recombinant proteins, such as antibodies, using Chinese hamster ovary (CHO) cells. In these circumstances, the virus or protein product is secreted into the medium by the cells; the cells themselves are not retrieved. Microcarriers are seeing a rising demand in cell therapy, which has overtaken vaccine production as the second-largest market sector.
Currently, the bulk of cell therapies use non-adherent hematopoietic lineage cells that don't need a support substrate. However, as adherent MSC and iPSC-based therapies gain therapeutic potential, there will be a greater need for biomanufacturing capacity that can produce these adherent cell types at higher volumes.
The United States is the worldwide leader in biopharmaceutical research and development and has the biggest market for biopharmaceuticals, making up a large portion of The United States has one of the best environments in the world for developing and selling pharmaceuticals. There aren't many market barriers. Its strengths include a patent and data protection system that encourages innovation, a science-based regulatory system that is thought to be the most strict in the world, the world's largest scientific research base made possible by academic institutions as well as decades of government funding for research, and strong capital markets.
The US market dominated the North America Microcarriers Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $651 million by 2028.The Canada market is poised to grow at a CAGR of 13.1% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 12.1% during (2022 - 2028).
Based on Consumables, the market is segmented into Microcarrier Beads and Media & Reagents. Based on Microcarrier Beads Type, the market is segmented into, Collagen Coated Beads, Cationic Beads, Protein Coated Beads, Untreated Beads and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations and Academic & Research Institutes. Based on Application, the market is segmented into Biopharmaceutical Production and Regenerative Medicine. Based on Biopharmaceutical Production Type, the market is segmented into Vaccine Production and Therapeutic Production. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Microcarriers Market is Predict to reach $2.4 Billion by 2028, at a CAGR of 11.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Sartorius Stedim Biotech S.A. (Sartorius AG), Corning Incorporated, Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf SE, HiMedia Laboratories Pvt. Ltd., and denovoMATRIX GmbH.
By Consumables
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
